<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; Aptness</title>
	<atom:link href="http://www.tapanray.in/tag/aptness/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Aptness Of Pharma Marketing Audit In Covid Days And Beyond</title>
		<link>http://www.tapanray.in/aptness-of-pharma-marketing-audit-in-covid-days-and-beyond/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=aptness-of-pharma-marketing-audit-in-covid-days-and-beyond</link>
		<comments>http://www.tapanray.in/aptness-of-pharma-marketing-audit-in-covid-days-and-beyond/#comments</comments>
		<pubDate>Mon, 21 Sep 2020 00:00:13 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Aptness]]></category>
		<category><![CDATA[audit]]></category>
		<category><![CDATA[company-specific]]></category>
		<category><![CDATA[Coronavirus]]></category>
		<category><![CDATA[Covid]]></category>
		<category><![CDATA[Covid-10]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[dovetail]]></category>
		<category><![CDATA[findings]]></category>
		<category><![CDATA[generic]]></category>
		<category><![CDATA[importance]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry-specific]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[Marketing Audit]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[normal]]></category>
		<category><![CDATA[Old]]></category>
		<category><![CDATA[pandemic]]></category>
		<category><![CDATA[periodically]]></category>
		<category><![CDATA[Pilman]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Relevance]]></category>
		<category><![CDATA[specific]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[Survey]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[trends]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10266</guid>
		<description><![CDATA[That, Covid-19 pandemic has changed the operational dynamics of many areas of the pharma industry, as compared to the old normal, is being felt by many. These changes generally fall into two categories. Some are broad industry specific changes, giving &#8230; <a href="http://www.tapanray.in/aptness-of-pharma-marketing-audit-in-covid-days-and-beyond/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/aptness-of-pharma-marketing-audit-in-covid-days-and-beyond/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
